Guardant Health [GH] vs Agilent Technologies [A] Detailed Stock Comparison

Guardant Health Inc.

NASDAQ
Loading...

Agilent Technologies Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Guardant Health Inc. wins in 4 metrics, Agilent Technologies Inc. wins in 15 metrics, with 0 ties. Agilent Technologies Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Guardant Health Inc. Agilent Technologies Inc. Better
P/E Ratio (TTM) -26.47 25.67 Agilent Technologies Inc.
Price-to-Book Ratio -113.87 4.76 Agilent Technologies Inc.
Debt-to-Equity Ratio -17.22 51.39 Agilent Technologies Inc.
PEG Ratio -2.38 -7.19 Guardant Health Inc.
EV/EBITDA -31.17 17.32 Agilent Technologies Inc.
Profit Margin (TTM) -42.39% 18.26% Agilent Technologies Inc.
Operating Margin (TTM) -42.91% 22.86% Agilent Technologies Inc.
EBITDA Margin (TTM) N/A 22.86% N/A
Return on Equity 419.18% 19.95% Guardant Health Inc.
Return on Assets (TTM) -15.59% 8.53% Agilent Technologies Inc.
Free Cash Flow (TTM) $-233.07M $1.15B Agilent Technologies Inc.
Dividend Yield N/A 0.68% N/A
1-Year Return 167.03% 10.90% Guardant Health Inc.
Price-to-Sales Ratio (TTM) 12.07 4.65 Agilent Technologies Inc.
Enterprise Value $12.36B $34.13B Agilent Technologies Inc.
EV/Revenue Ratio 12.59 4.83 Agilent Technologies Inc.
Gross Profit Margin (TTM) 64.63% 52.61% Guardant Health Inc.
Revenue per Share (TTM) $8 $25 Agilent Technologies Inc.
Earnings per Share (Diluted) $-3.32 $4.53 Agilent Technologies Inc.
Beta (Stock Volatility) 1.65 1.30 Agilent Technologies Inc.
Short % of Float 10.93% 1.83% Agilent Technologies Inc.

Guardant Health Inc. vs Agilent Technologies Inc. Stock Performance Analysis

Loading Price Chart...

GH
A

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Guardant Health Inc.-1.37%3.95%36.77%48.91%26.44%27.60%
Agilent Technologies Inc.-3.41%-2.11%3.78%7.87%-3.22%-4.70%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Guardant Health Inc.167.03%254.87%9.50%350.75%350.75%350.75%
Agilent Technologies Inc.10.90%7.19%-10.46%186.24%282.67%444.17%

Performance & Financial Health Analysis: Guardant Health Inc. vs Agilent Technologies Inc.

MetricGHA
Market Information
Market Cap i$11.53B$32.65B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i2,518,2321,922,585
90 Day Avg. Volume i2,085,5571,892,452
Last Close$129.82$131.46
52 Week Range$40.35 - $135.00$108.35 - $160.27
% from 52W High-3.84%-17.98%
All-Time High$181.07 (Feb 08, 2021)$179.57 (Aug 30, 2021)
% from All-Time High-28.30%-26.79%
Growth Metrics
Quarterly Revenue Growth0.39%0.07%
Quarterly Earnings Growth0.39%-0.04%
Financial Health
Profit Margin (TTM) i-0.42%0.18%
Operating Margin (TTM) i-0.43%0.23%
Return on Equity (TTM) i4.19%0.20%
Debt to Equity (MRQ) i-17.2251.39
Cash & Liquidity
Book Value per Share (MRQ)$-0.76$24.44
Cash per Share (MRQ)$9.16$6.22
Operating Cash Flow (TTM) i$-184,760,000$1.40B
Levered Free Cash Flow (TTM) i$-88,105,872$855.88M
Dividends
Last 12-Month Dividend Yield iN/A0.68%
Last 12-Month Dividend iN/A$1.01

Valuation & Enterprise Metrics Analysis: Guardant Health Inc. vs Agilent Technologies Inc.

MetricGH (Apr 24, 2026)A (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i-26.4725.67
Forward P/E i-129.0817.67
PEG Ratio i-2.38-7.19
Price to Sales (TTM) i12.074.65
Price to Book (MRQ) i-113.874.76
Market Capitalization
Market Capitalization i$11.53B$32.65B
Enterprise Value i$12.36B$34.13B
Enterprise Value Metrics
Enterprise to Revenue i12.594.83
Enterprise to EBITDA i-31.1717.32
Risk & Other Metrics
Beta i1.651.30
Book Value per Share (MRQ) i$-0.76$24.44

Financial Statements Comparison: Guardant Health Inc. vs Agilent Technologies Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricGH (2025)A (2025)
Revenue/Sales i982.02M6.95B
Cost of Goods Sold i349.01M3.31B
COGS % of Revenue i35.5%47.6%
Gross Profit i633.01M3.64B
Gross Margin i64.5%52.4%
Research & Development i364.19M455.00M
Operating Income (EBIT) i-437.25M1.48B
Operating Margin i-44.5%21.3%
EBITDA i-373.91M1.84B
EBITDA Margin i-38.1%26.4%
Pre-Tax Income i-417.54M1.44B
Pre-Tax Income % of Revenue i-42.5%20.7%
Income Tax i-1.26M132.00M
Income Tax % of Revenue i-0.1%1.9%
Net Income (Profit) i-416.28M1.30B
Profit Margin i-42.4%18.8%

Balance Sheet & Liquidity Metrics

MetricGH (2025)A (2025)
Cash & Equivalents i378.20M1.79B
Total Current Assets i1.47B4.59B
Total Current Assets % of Revenue i149.3%66.1%
Total Current Liabilities i302.73M2.35B
Total Current Liabilities % of Revenue i30.8%33.8%
Long-Term Debt i1.68B3.05B
Long-Term Debt % of Revenue i171.3%43.9%
Total Shareholders Equity i-99.31M6.74B
Retained Earnings i-2.99B1.39B
Retained Earnings % of Revenue i-304.9%20.0%
Property, Plant & Equipment i158.85M0

Cash Flow Statement Comparison

MetricGH (2025)A (2025)
Operating Cash Flow i-230.19M1.51B
Operating Cash Flow % of Revenue i-23.4%21.7%
Capital Expenditures i-48.31M-407.00M
Free Cash Flow i-233.07M1.15B
FCF Margin i-23.7%16.6%
Debt Repayment iN/A-3.00M
Common Stock Repurchase i-45.01M-425.00M

Short Interest & Institutional Ownership Analysis

MetricGHA
Shares Short i13.70M4.55M
Short Ratio i7.501.93
Short % of Float i10.93%1.83%
Shares Outstanding i130.64M282.70M
Float Shares i125.75M281.64M
% Held by Insiders i4.04%0.19%
% Held by Institutions i101.22%93.87%
% Held by Public i-5.26%5.94%

Dividend Analysis & Yield Comparison: Guardant Health Inc. vs Agilent Technologies Inc.

MetricGHA
Last 12-Month Dividend iN/A$1.01
Last 12-Month Dividend Yield iN/A0.68%
3-Year Avg Annual Dividend iN/A$0.97
3-Year Avg Dividend Yield iN/A0.18%
3-Year Total Dividends iN/A$2.91
Ex-Dividend DateN/AJan 06, 2026